Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients

Improved prognostic stratification of patients with TNM stage II colorectal cancer (CRC) is desired, since 20–30% of high‐risk stage II patients may die within five years of diagnosis. This study was conducted to investigate REarranged during Transfection (RET) gene promoter CpG island methylation a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Draht, Muriel X.G., Smits, Kim M., Tournier, Benjamin, Jooste, Valerie, Chapusot, Caroline, Carvalho, Beatriz, Cleven, Arjen H.G., Derks, Sarah, Wouters, Kim A.D., Belt, Eric J.T., Stockmann, Hein B.A.C., Bril, Herman, Weijenberg, Matty P., van den Brandt, Piet A., de Bruïne, Adriaan P., Herman, James G., Meijer, Gerrit A., Piard, Françoise, Melotte, Veerle, van Engeland, Manon
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2014
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528631/
https://ncbi.nlm.nih.gov/pubmed/24560444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.01.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados